About Ferring Pharmaceuticals
Ferring Pharmaceuticals is a company based in Saint-prex (Switzerland) founded in 1950. The company has 336 employees as of September 30, 2024. Ferring Pharmaceuticals has completed 2 acquisitions, including Cytokine PharmaSciences and Rebiotix. Ferring Pharmaceuticals operates in a competitive market with competitors including GE Healthcare, Medtronic, Boston Scientific, Avidity Biosciences and Commure, among others.
- Headquarter Saint-prex, Switzerland
- Employees 336 as on 30 Sep, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$178.66 M (USD)25as on Dec 31, 2022
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
336
as on Sep 30, 2024
-
Investments & Acquisitions
Cytokine PharmaSciences
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Ferring Pharmaceuticals
Unlock access to complete
Unlock access to complete
Leadership Team
71 people
Sales and Marketing
56 people
Product Management Team
47 people
Software Development Team
45 people
Senior Team
39 people
Finance and Accounting
38 people
Operations Team
14 people
Head Team
12 people
Unlock access to complete
Funding Insights of Ferring Pharmaceuticals
Detailed funding history for Ferring Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ferring Pharmaceuticals
Ferring Pharmaceuticals has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Cytokine PharmaSciences and Rebiotix.
Investment portfolio details for Ferring Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Microbiota restoration therapies are developed for gastrointestinal infections.
|
Locked | Locked | 2011 | Locked | |
|
Controlled-release drug delivery products for women's health are developed.
|
Locked | Locked | 1993 | Locked |
Complete acquisition details for Ferring Pharmaceuticals
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Ferring Pharmaceuticals
Detailed financials for Ferring Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ferring Pharmaceuticals Comparisons
Peer comparison for Ferring Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ferring Pharmaceuticals
Ferring Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GE Healthcare, Medtronic, Boston Scientific, Avidity Biosciences and Commure, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Materials management solutions are provided for healthcare organizations.
|
|
| Locked | Locked | Locked |
Medical equipment for treating over 30 chronic diseases is developed.
|
|
| Locked | Locked | Locked |
Wide range of medical devices
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Complex healthcare challenges are addressed through technology solutions by Commure.
|
|
| Locked | Locked | Locked |
Biosciences, medication delivery, and renal products are developed and marketed.
|
Detailed competitors of Ferring Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ferring Pharmaceuticals
Complete news archive for Ferring Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ferring Pharmaceuticals
Ferring Pharmaceuticals was founded in 1950.
Ferring Pharmaceuticals is headquartered in Saint-prex, Switzerland. It is registered at Saint-prex, Vaud, Switzerland.
As of Sep 30, 2024, the latest employee count at Ferring Pharmaceuticals is 336.
Annual revenue of Ferring Pharmaceuticals is $178.66M as on Dec 31, 2022.
Ferring Pharmaceuticals, based in Saint-prex, focuses on providing healthcare solutions, diversified pharmaceuticals, and drugs. Provider of drugs in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopaedics. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Ferring Pharmaceuticals's top competitors include GE Healthcare, Medtronic and Boston Scientific.
Ferring Pharmaceuticals has made 2 acquisitions, including Cytokine PharmaSciences, and Rebiotix.